시장보고서

상품코드

1842052

세계의 불임 검사 시장 규모, 점유율, 동향 분석 : 검사 유형별, 용도별, 시료 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Fertility Test Market Size, Share & Trends Analysis Report By Test Type, By Application, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033

발행일: 2025년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

불임 검사 시장 요약

세계의 불임 검사 시장 규모는 2024년에 73억 8,000만 달러로 추계되며, 2033년에는 147억 4,000만 달러에 달할 것으로 예측되며, 2025-2033년 CAGR은 8.08%로 성장합니다.

이러한 성장은 생활습관의 변화, 스트레스 수준 증가, 임신 지연, 환경오염 물질에 대한 노출 등이 원인으로 지목되고 있습니다.

또한 생식 건강에 대한 인식이 높아지면서 남녀 모두 불임 검사가 받아들여지고 조기 진단과 개입이 장려되고 있습니다. 또한 다낭성난소증후군(PCOS), 자궁내막증 등 생식장애의 유병률이 높아지면서 더 많은 사람들이 검사를 받고 있습니다.

남녀 모두 불임의 비율이 증가하고 있는 것은 시장 성장을 가속하는 중요한 요인입니다. 세계보건기구(WHO)가 2023년 4월 발표한 보고서에 따르면 불임은 성인 6명 중 1명, 즉 인구의 17.5%가 앓고 있는 것으로 나타났습니다. 이 보고서에 따르면 불임의 비율은 지역과 소득 수준에 따라 일관되게 나타났으며, 평생 유병률은 고소득 국가에서 17.8%, 중저소득 국가에서 16.5%로 나타났습니다. 이는 불임이 특정 계층이나 지역에 국한된 문제가 아니라 전 세계 사람들에게 심각한 문제임을 시사합니다.

시장 점유율 분석 : 지역별(2024년·2033년)
시장 대시보드 : 지역별
세계 시장 스냅숏 : 지역별
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 불임 검사 시장 : 경쟁 구도

주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁 분류
주요 기업의 시장 현황 분석(2024년)
기업 리스트

KSA 25.11.07

Fertility Test Market Summary

The global fertility test market size was estimated at USD 7.38 billion in 2024 and is projected to reach USD 14.74 billion in 2033, growing at a CAGR of 8.08% from 2025 to 2033. This growth is attributed to lifestyle changes, higher stress levels, delayed pregnancies, and exposure to environmental pollutants.

In addition, there is a growing awareness of reproductive health and greater acceptance of fertility testing among both men and women, which encourages early diagnosis and intervention. Moreover, the rising prevalence of reproductive disorders, such as polycystic ovary syndrome (PCOS) and endometriosis, is encouraging more individuals to seek evaluations.

The increasing rates of infertility among both men and women are a significant factor driving the growth of the market. As per the report published by the World Health Organization (WHO) in April 2023, infertility affects approximately 1 in 6 adults, or 17.5% of the population. The report indicates that infertility rates are consistent across various regions and income levels, with a lifetime prevalence of 17.8% in high-income countries and 16.5% in low- and middle-income countries. This suggests that infertility is not confined to specific demographics or areas, making it a serious challenge for people worldwide.

Global Fertility Test Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global fertility test market report based on test type, application, sample type, end-use, and region:

Test Type Outlook (Revenue, USD Billion, 2021 - 2033)
Ovulation Prediction Tests
Female Fertility Hormone Tests
Male Fertility Tests
Comprehensive Fertility Panels
Application Outlook (Revenue, USD Billion, 2021 - 2033)
Female Fertility Testing
Male Fertility Testing
Sample Type Outlook (Revenue, USD Billion, 2021 - 2033)
Urine-based
Saliva-based
Blood-based
Semen-based
End-use Outlook (Revenue, USD Billion, 2021 - 2033)
Home Care Settings
Hospitals
Fertility Clinics
Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1 Market Segmentation & Scope
1.2 Segment Definitions
- 1.2.1 Test Type
- 1.2.2 Application
- 1.2.3 Sample Type
- 1.2.4 End Use
1.3 Research Methodology
- 1.3.1 Commodity flow analysis
- 1.3.2 Information procurement
  - 1.3.2.1 Purchased database
  - 1.3.2.2 GVR's internal database
  - 1.3.2.3 Primary research
1.4 Information or Data Analysis
- 1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 List of Secondary Sources
1.7 List of Abbreviations
1.8 Objectives

Chapter 2. Executive Summary

2.1 Market Snapshot
2.2 Market Segmentation
2.4 Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

3.1 Market Lineage Outlook
3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
3.3 Industry Analysis Tools
- 3.3.1 Porter's Five Forces Analysis
- 3.3.2 PESTLE Analysis

Chapter 4. Fertility Test Market: Type Estimates & Trend Analysis

4.1 Fertility Test Market: Test Type Segment Dashboard
4.2 Test Type Movement & Market Share Analysis, 2024 & 2033
4.3 Global Fertility Test Market Size Estimates & Forecast, by Test Type
- 4.3.1 Ovulation Prediction Tests
  - 4.3.1.1 Ovulation Prediction Tests Market, 2021 - 2033 (USD Billion)
- 4.3.2 Female Fertility Hormone Tests
  - 4.3.2.1 Female Fertility Hormone Tests Market, 2021 - 2033 (USD Billion)
- 4.3.3 Male Fertility Tests
  - 4.3.3.1 Male Fertility Tests Market, 2021 - 2033 (USD Billion)
- 4.3.4 Comprehensive Fertility Panels
  - 4.3.4.1 Comprehensive Fertility Panels Market, 2021 - 2033 (USD Billion)

Chapter 5. Fertility Test Market: Application Estimates & Trend Analysis

5.1 Fertility Test Market: Application Segment Dashboard
5.2 Application Movement & Market Share Analysis, 2024 & 2033
5.3 Global Fertility Test Market Size Estimates & Forecast, by Application
- 5.3.1 Female Fertility Testing
  - 5.3.1.1 Female Fertility Testing Market, 2021 - 2033 (USD Billion)
- 5.3.2 Male Fertility Testing
  - 5.3.2.1 Male Fertility Testing Market, 2021 - 2033 (USD Billion)

Chapter 6. Fertility Test Market: Sample Type Estimates & Trend Analysis

6.1 Fertility Test Market: Sample Type Segment Dashboard
6.2 Sample Type Movement & Market Share Analysis, 2024 & 2033
6.3 Global Fertility Test Market Size Estimates & Forecast, by Sample Type
- 6.3.1 Urine-Based
  - 6.3.1.1 Urine-Based Market, 2021 - 2033 (USD Billion)
- 6.3.2 Saliva-Based
  - 6.3.2.1 Saliva-Based Market, 2021 - 2033 (USD Billion)
- 6.3.3 Blood-Based
  - 6.3.3.1 Blood-Based Market, 2021 - 2033 (USD Billion)
- 6.3.4 Semen-Based
  - 6.3.4.1 Semen-Based Market, 2021 - 2033 (USD Billion)

Chapter 7. Fertility Test Market: End Use Estimates & Trend Analysis

7.1 Fertility Test Market: End Use Segment Dashboard
7.2 End Use Movement & Market Share Analysis, 2024 & 2033
7.3 Global Fertility Test Market Size Estimates & Forecast, by End Use
- 7.3.1 Home Care Settings
  - 7.3.1.1 Home Care Settings Market, 2021 - 2033 (USD Billion)
- 7.3.2 Hospitals
  - 7.3.2.1 Hospitals Market, 2021 - 2033 (USD Billion)
- 7.3.3 Fertility Clinics
  - 7.3.3.1 Fertility Clinics Market, 2021 - 2033 (USD Billion)
- 7.3.4 Others
  - 7.3.4.1 Others Market, 2021 - 2033 (USD Billion)

Chapter 8. Fertility Test Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Regulatory framework
  - 8.4.1.3. Competitive scenario
  - 8.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
- 8.4.2. Canada
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Regulatory framework
  - 8.4.2.3. Competitive scenario
  - 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.4.3. Mexico
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Regulatory framework
  - 8.4.3.3. Competitive scenario
  - 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Regulatory framework
  - 8.5.1.3. Competitive scenario
  - 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Regulatory framework
  - 8.5.2.3. Competitive scenario
  - 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Regulatory framework
  - 8.5.3.3. Competitive scenario
  - 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Regulatory framework
  - 8.5.4.3. Competitive scenario
  - 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Regulatory framework
  - 8.5.5.3. Competitive scenario
  - 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.6. Norway
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Regulatory framework
  - 8.5.6.3. Competitive scenario
  - 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Regulatory framework
  - 8.5.7.3. Competitive scenario
  - 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.5.8. Denmark
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Regulatory framework
  - 8.5.8.3. Competitive scenario
  - 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Regulatory framework
  - 8.6.1.3. Competitive scenario
  - 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.6.2. China
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Regulatory framework
  - 8.6.2.3. Competitive scenario
  - 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.6.3. India
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Regulatory framework
  - 8.6.3.3. Competitive scenario
  - 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.6.4. Australia
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Regulatory framework
  - 8.6.4.3. Competitive scenario
  - 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Regulatory framework
  - 8.6.5.3. Competitive scenario
  - 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Regulatory framework
  - 8.6.6.3. Competitive scenario
  - 8.6.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Billion)
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Regulatory framework
  - 8.7.1.3. Competitive scenario
  - 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.7.2. Argentina
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Regulatory framework
  - 8.7.2.3. Competitive scenario
  - 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Billion)
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Regulatory framework
  - 8.8.1.3. Competitive scenario
  - 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Regulatory framework
  - 8.8.2.3. Competitive scenario
  - 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Regulatory framework
  - 8.8.3.3. Competitive scenario
  - 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Billion)
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Regulatory framework
  - 8.8.4.3. Competitive scenario
  - 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 9. Fertility Test Market: Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Key company market position analysis, 2024
9.4. List of Companies
- 9.4.1. Quest Diagnostics
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Service benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Mayo Clinic Laboratories
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Service benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Ovation Fertility
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Service benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Illume Fertility
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Service benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Proov
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Service benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. BioMerieux
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Service benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. Labcorp
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Service benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. CCRM Fertility
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Service benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Hertility Health
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Service benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. Maven Clinic Co.
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Service benchmarking
  - 9.4.10.4. Strategic initiatives

세계의 불임 검사 시장 규모, 점유율, 동향 분석 : 검사 유형별, 용도별, 시료 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Fertility Test Market Size, Share & Trends Analysis Report By Test Type, By Application, By Sample Type, By End-use, By Region, And Segment Forecasts, 2025 - 2033

불임 검사 시장 요약

목차

제1장 분석 방법·범위

제2장 개요

제3장 시장의 변동 요인·동향·범위

제4장 불임 검사 시장 : 검사 유형별 추정·동향 분석

제5장 불임 검사 시장 : 용도별 추정·동향 분석

제6장 불임 검사 시장 : 시료 유형별 추정·동향 분석

제7장 불임 검사 시장 : 최종 용도별 추정·동향 분석

제8장 불임 검사 시장 : 지역별 추정·동향 분석